Acute Leukemias
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases (NCT02145039) | Masonic Cancer Center, University of Minnesota | 2014-10-01 |
| A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene (NCT02141828) | Epizyme, Inc. | 2014-05-01 |
| Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia (NCT01826214) | Novartis Pharmaceuticals | 2013-05-01 |
| Providing Access to Cord Blood Units for Transplants (NCT01479582) | National Cancer Institute (NCI) | 2011-10-27 |
| Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) (NCT01339988) | Tel-Aviv Sourasky Medical Center | 2011-06-01 |
| Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells (NCT01919866) | University Children's Hospital Tuebingen | 2004-03-01 |
Track Acute Leukemias automatically
Every clearance here is in the API, with alerts when new ones post.